Fig 1.
CABG, coronary artery bypass graft; IV, intravenous; PCI, percutaneous coronary intervention.
Table 1.
Baseline characteristics categorized by treatment intervention.
Fig 2.
Study outcomes across randomization groups.
Patients randomized to Group 1 (standard of care), Group 2 (intravenous placebo infusion), and Group 3 (intravenous furosemide infusion). Groups 2 and 3 underwent biweekly infusion visits for 30 days that included a HF-Care protocol. Changes in weight (a) and urine output (b) post- vs. pre-infusion for Group 2 and Group 3. Primary study outcome results (c) 30-day rehospitalization for ADHF in all three groups. ADHF, acute decompensated heart failure; HF, heart failure; IV, intravenous.
Table 2.
Infusion visit metrics changes (post infusion-pre infusion) categorized by intervention group.
Table 3.
Changes in study outcome at 30 days compared to baseline categorized by treatment intervention group.